Imogen Walpole
YOU?
Author Swipe
Computational repurposing of oncology drugs through off‐target drug binding interactions from pharmacological databases Open
Purpose Systematic repurposing of approved medicines for another indication may accelerate drug development in oncology. We present a strategy combining biomarker testing with drug repurposing to identify new treatments for patients with a…
Computational repurposing of oncology drugs through off-target drug binding interactions from pharmacological databases Open
PURPOSE Systematic repurposing of approved medicine for another indication represents an attractive strategy to accelerating drug development in oncology. Herein we present a strategy of combining biomarker testing with drug repurposing to…
Surveillance imaging with FDG-PET/CT in the post-operative follow-up of stage 3 melanoma Open
As early detection of recurrent melanoma maximizes treatment options, patients usually undergo post-operative imaging surveillance, increasingly with FDG-PET/CT (PET). To assess this, we evaluated stage 3 melanoma patients who underwent pr…